Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
Holding ACTU?
Track your performance easily
CHICAGO and FORT WORTH, Texas, Sept. 11, 2024 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that the U.S.
...Read more
ACTU News on the Web
Yahoo Finance
Neutral
Yahoo Finance
Neutral
Yahoo Finance
Neutral
TalkMarkets
Neutral
Yahoo Finance
Neutral
Yahoo Finance
Neutral
TalkMarkets
Neutral
Yahoo Finance
Neutral
News Score - Last 7 Days
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is ACTU’s Media Buzz Sentiment?
1 articles about ACTU were published this week. In an average week, 1.25 articles are published.
What is ACTU’s weekly average amount of articles?
In an average week, 1.25 articles about ACTU are published.
What is ACTU’s News Sentiment?
50% of articles about ACTU were positive this week, compared to its sector average of 61%.